Institutional Review Boards
Institutional review board (IRB)- administrative body ensuring human subjects protected in research
Often affiliated with university or hospitals
Review ethics protocols that include
How study will advance existing research
Who will be recruited- ages (especially If they’re minors), gender, race, sexuality
Ensure you engage appropriate populations
Making sure you protect vulnerable populations
All activities participants are asked to do and their methods
Interview, focus group, clinical trials, etc.
Consent process & compensation
Verbal vs written consent
What is in consent form?
Is compensation coercive?
Other aspects of a project
Timeline?
Done in phases?
Personnel?
Certification to work w/ human subjects
Usually there’s a template for this
History of IRBs
Arose after violations of human rights in research (WWII Nazi & Japanese research)
1950s-60s- early emergence
1971- Stanford prison experiment
1972- public revelation of Tuskegee syphilis experiment
1979- Belmont report
Established principles of respect for autonomy, beneficence, justice in research
Common rule 1981- formal guidelines for IRBs
Look different in different places
Ex- low risk social science research
May not be subject to IRB review in some European countries because you’re likely just talking to people
In US- still needs to be reviewed if you’re interviewing people to look for general trends
Review all kinds of research and can specialize in some research
Hospital IRBs- clinical trials/studies
Social-behavioral IRBs- tends to review empirical social science & education research
Private IRBs- for-profit IRBs that companies can hire to review their research
Characteristics
At least 5 members of diverse backgrounds
At least 1 scientist/researcher
At least 1 community member that’s not staff, student, or researcher in the university
Can be paid/unpaid
Protect human subjects’ interests
Can be held liable for harm occurring to participants
Reason being that they did not thoroughly review protocol and account for potential risks to participants
Participants need to be fully aware of risks and IRB needs to carefully review protocol
Completes these tasks:
Ensures study personnel have necessary certifications
Initial review of ethics protocols for study
Work with researchers to make any adjustments
Review modifications to initial protocol as study expands/changes
In-depth audits, annual review of select protocols as needed
Can access confidential records of project for this
Need IRB approval to start human research
Most cases- IRBs work with researchers to adjust study design to ensure participants be protected instead of outright denying researchers ability to begin their study
Can also outright approve/deny
Follow Common Rule (rev. 2018)
Sets requirements for
IRB membership
Consent process
Types of ethics protocol reviews
Vulnerable populations
Prisoners (do not necessarily have autonomy)
children (mostly bc of extra documentation/paperwork)
students (possible coercion to participate, especially if they’re students @ the university where research is happening)
pregnant individuals
Populations that may be considered vulnerable but technically aren’t in some cases
Elderly (not vulnerable if they have clarity of mind)
Mental illness/personality disorders (not vulnerable if they’re stable on medication)
But IRB will ask how you ensure they have DMC and capacity to give consent
Other important parts
Must inform participants if data used for something else other than study
Must inform participants if their biospecimens will be used for purposes where there is commercial profit
Educational research is exempt from review if data is being gathered on educational practices already in use
You can’t determine whether it’s human subject research or not
Consent forms must be made publicly available online for some federal-funded clinical trials
IRBs interpret common rule guidelines
Different IRBs can make diff decisions
3 types of IRB review - IRB decides which one
Full review- all members of committee come together and read protocol and decide any modifications
Usually for studies with potential risk
Example- clinical trials for new medication
Expedited- only review by 1 member of the IRB
For studies with minimal risk but still considered human subjects research
Member chosen based on different characteristics
Example- study interviewing patients about experiences accessing mental healthcare
Exempt- ethics protocol is submitted but not reviewed by IRB bc they deem it not to be human subject research
Example- studying how much information students retain after class
Time length depends on IRB but generally takes a while
Types of research not reviewed by IRB
Not direct work with human subjects
Animal research- reviewed by Institutional Animal Care and Use Committee
Research using existing de-identified data sets
Using deidentified human specimens
Educational research
Consider following in ethics protocols review
Confidentiality
Data management & security
Compensation of participants
Special accommodations for vulnerable populations
Risks and benefits
Placebos in clinical research
Confidentiality is the main concern
Common suggestions
Never publicly name a research participant
But they can talk about
Data distinguished with participant ID # instead of their name
In presentation & published reports- participants given pseudonyms where appropriate
Certain details not provided if they’d result in identification of participants
Data management is another important concern
Electronic storage needs to be encrypted
Physical forms needed to be stored in locked files in locked office
Only people designated as researchers and members of IRB can access
Store data in separate location than data identifying ID# and their name
Compensation
Will they paid?
How much will they paid?
Is compensation coercive?
This depends on who’s compensated
Not compensating also unethical
Medical care provided for free viewed as “benefit” not as compensation
Vulnerable populations special considerations
Pregnant people- Is the risk to the fetus mitigated? What happens if participant becomes pregnant?
Children- Can they give assent? Should parent/guardian consent be waived?
Prisoners- Do they have ability to freely decide? Autonomy is impacted
Students- Ensure grades and relationships to university will not be impacted
Risk and benefits assessment
Risk should be minimized and/or made relative to benefits
Placebos
Should only be used when patients not put at undue risk by not receiving active treatment
Institutional review board (IRB)- administrative body ensuring human subjects protected in research
Often affiliated with university or hospitals
Review ethics protocols that include
How study will advance existing research
Who will be recruited- ages (especially If they’re minors), gender, race, sexuality
Ensure you engage appropriate populations
Making sure you protect vulnerable populations
All activities participants are asked to do and their methods
Interview, focus group, clinical trials, etc.
Consent process & compensation
Verbal vs written consent
What is in consent form?
Is compensation coercive?
Other aspects of a project
Timeline?
Done in phases?
Personnel?
Certification to work w/ human subjects
Usually there’s a template for this
History of IRBs
Arose after violations of human rights in research (WWII Nazi & Japanese research)
1950s-60s- early emergence
1971- Stanford prison experiment
1972- public revelation of Tuskegee syphilis experiment
1979- Belmont report
Established principles of respect for autonomy, beneficence, justice in research
Common rule 1981- formal guidelines for IRBs
Look different in different places
Ex- low risk social science research
May not be subject to IRB review in some European countries because you’re likely just talking to people
In US- still needs to be reviewed if you’re interviewing people to look for general trends
Review all kinds of research and can specialize in some research
Hospital IRBs- clinical trials/studies
Social-behavioral IRBs- tends to review empirical social science & education research
Private IRBs- for-profit IRBs that companies can hire to review their research
Characteristics
At least 5 members of diverse backgrounds
At least 1 scientist/researcher
At least 1 community member that’s not staff, student, or researcher in the university
Can be paid/unpaid
Protect human subjects’ interests
Can be held liable for harm occurring to participants
Reason being that they did not thoroughly review protocol and account for potential risks to participants
Participants need to be fully aware of risks and IRB needs to carefully review protocol
Completes these tasks:
Ensures study personnel have necessary certifications
Initial review of ethics protocols for study
Work with researchers to make any adjustments
Review modifications to initial protocol as study expands/changes
In-depth audits, annual review of select protocols as needed
Can access confidential records of project for this
Need IRB approval to start human research
Most cases- IRBs work with researchers to adjust study design to ensure participants be protected instead of outright denying researchers ability to begin their study
Can also outright approve/deny
Follow Common Rule (rev. 2018)
Sets requirements for
IRB membership
Consent process
Types of ethics protocol reviews
Vulnerable populations
Prisoners (do not necessarily have autonomy)
children (mostly bc of extra documentation/paperwork)
students (possible coercion to participate, especially if they’re students @ the university where research is happening)
pregnant individuals
Populations that may be considered vulnerable but technically aren’t in some cases
Elderly (not vulnerable if they have clarity of mind)
Mental illness/personality disorders (not vulnerable if they’re stable on medication)
But IRB will ask how you ensure they have DMC and capacity to give consent
Other important parts
Must inform participants if data used for something else other than study
Must inform participants if their biospecimens will be used for purposes where there is commercial profit
Educational research is exempt from review if data is being gathered on educational practices already in use
You can’t determine whether it’s human subject research or not
Consent forms must be made publicly available online for some federal-funded clinical trials
IRBs interpret common rule guidelines
Different IRBs can make diff decisions
3 types of IRB review - IRB decides which one
Full review- all members of committee come together and read protocol and decide any modifications
Usually for studies with potential risk
Example- clinical trials for new medication
Expedited- only review by 1 member of the IRB
For studies with minimal risk but still considered human subjects research
Member chosen based on different characteristics
Example- study interviewing patients about experiences accessing mental healthcare
Exempt- ethics protocol is submitted but not reviewed by IRB bc they deem it not to be human subject research
Example- studying how much information students retain after class
Time length depends on IRB but generally takes a while
Types of research not reviewed by IRB
Not direct work with human subjects
Animal research- reviewed by Institutional Animal Care and Use Committee
Research using existing de-identified data sets
Using deidentified human specimens
Educational research
Consider following in ethics protocols review
Confidentiality
Data management & security
Compensation of participants
Special accommodations for vulnerable populations
Risks and benefits
Placebos in clinical research
Confidentiality is the main concern
Common suggestions
Never publicly name a research participant
But they can talk about
Data distinguished with participant ID # instead of their name
In presentation & published reports- participants given pseudonyms where appropriate
Certain details not provided if they’d result in identification of participants
Data management is another important concern
Electronic storage needs to be encrypted
Physical forms needed to be stored in locked files in locked office
Only people designated as researchers and members of IRB can access
Store data in separate location than data identifying ID# and their name
Compensation
Will they paid?
How much will they paid?
Is compensation coercive?
This depends on who’s compensated
Not compensating also unethical
Medical care provided for free viewed as “benefit” not as compensation
Vulnerable populations special considerations
Pregnant people- Is the risk to the fetus mitigated? What happens if participant becomes pregnant?
Children- Can they give assent? Should parent/guardian consent be waived?
Prisoners- Do they have ability to freely decide? Autonomy is impacted
Students- Ensure grades and relationships to university will not be impacted
Risk and benefits assessment
Risk should be minimized and/or made relative to benefits
Placebos
Should only be used when patients not put at undue risk by not receiving active treatment